BIO 2019 Biotech Breakfast in Philadelphia
We are excited to be attending the NSW Government’s biotech breakfast at BIO 2019, a gathering of leaders in the biotechnology and pharmaceutical industry next week in Philadelphia.
Lisa Nelson, CEO of Scientia Clinical Research, will join a panel of experts to reveal how New South Wales, Australia has the capabilities and the policy environment to facilitate fast, high quality and cost-effective clinical trials from approval to completion.
We look forward to revealing a new resource that is now available to optimise your clinical trial experience in NSW.
The clinical trials panel includes:
- Lisa Nelson, CEO, Scientia Clinical Research
- Anne O’Neill, Director Enterprise and International Partnerships, NSW Ministry of Health
- David Lloyd, Managing Director, Southern Star Research
- David Barda, Head of Business Development & Innovation, Garvan Institute of Medical Research